Development of a high-throughput screen for soluble epoxide hydrolase inhibition
- 11 May 2006
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 355 (1) , 71-80
- https://doi.org/10.1016/j.ab.2006.04.045
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- High-throughput pharmacokinetic method: Cassette dosing in mice associated with minuscule serial bleedings and LC/MS/MS analysisAnalytica Chimica Acta, 2006
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- EPOXIDE HYDROLASES: Mechanisms, Inhibitor Designs, and Biological RolesAnnual Review of Pharmacology and Toxicology, 2005
- Optimization of Amide-Based Inhibitors of Soluble Epoxide Hydrolase with Improved Water SolubilityJournal of Medicinal Chemistry, 2005
- Design, Synthesis, and Biological Activity of 1,3-Disubstituted Ureas as Potent Inhibitors of the Soluble Epoxide Hydrolase of Increased Water SolubilityJournal of Medicinal Chemistry, 2004
- High-Throughput screeening assays for CYP2B6 metabolism and inhibition usuing fluorogenic vivid substratesAAPS PharmSci, 2003
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Role of Cytochrome P-450 Enzymes and Metabolites of Arachidonic Acid in the Control of Vascular ToneJournal of Vascular Research, 1995
- Mammalian Epoxide Hydrases: Inducible Enzymes Catalysing the Inactivation of Carcinogenic and Cytotoxic Metabolites Derived from Aromatic and Olefinic CompoundsXenobiotica, 1973